scholarly journals Intraoral and extraoral approach for surgical treatment of Eagle's syndrome: a retrospective study

2021 ◽  
Author(s):  
Jing Wang ◽  
Yan Liu ◽  
Zhi Bin Wang ◽  
Kai Sheng Yan
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Eagle’S Syndrome

scholarly journals The Dose of Somatostatin Analogues during Pre-Surgical Treatment Is a Key Factor to Achieve Surgical Remission in Acromegaly

Endocrines ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 241-250
Author(s):  
Marta Araujo-Castro ◽  
Eider Pascual-Corrales ◽  
Héctor Pian ◽  
Ignacio Ruz-Caracuel ◽  
Alberto Acitores Cancela ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Surgical Outcomes ◽  
Pituitary Adenomas ◽  
Somatostatin Analogues ◽  
Beneficial Effects ◽  
Key Factor ◽  
Long Acting ◽  
First Time ◽  
Endocrine Complications

Purpose: to determine whether pre-surgical treatment using long-acting somatostatin analogues (SSAs) may improve surgical outcomes in acromegaly. Methods: retrospective study of 48 patients with acromegaly operated by endoscopic transsphenoidal approach and for first time. Surgical remission was evaluated based on the 2010 criteria. Results: most patients, 83.3% (n = 40), harbored macroadenomas and 31.3% (n = 15) invasive pituitary adenomas. In this case, 14 patients were treated with lanreotide LAR and 6 with octreotide LAR, median monthly doses of 97.5 [range 60–120] and 20 [range 20–30] mg, respectively, for at least 3 months preoperatively. Presurgical variables were comparable between pre-treated and untreated patients (p > 0.05). Surgical remission was more frequent in those pre-treated with monthly doses ≥90 mg of lanreotide or ≥30 mg of octreotide than in untreated or pre-treated with lower doses (OR = 4.64, p = 0.025). However, no differences were found between pre-treated and untreated patients when lower doses were included or between those treated for longer than 6 months compared to those untreated or pre-treated for shorter than 6 months. Similarly, no differences were found either in terms of surgical or endocrine complications (OR = 0.65, p = 0.570), independently of the doses and the duration of SSA treatment (p > 0.05). Conclusions: the dose of SSAs is a key factor during pre-surgical treatment, since the beneficial effects in surgical remission were observed with monthly doses equal or higher than 90 mg of lanreotide and 30 mg of octreotide, but not with lower doses.

scholarly journals Eagle’s Syndrome, from clinical presentation to diagnosis and surgical treatment: a case report

2018 ◽  
Vol 38 (2) ◽  
pp. 166-169 ◽  
Author(s):  
S. SACCOMANNO ◽  
F. GRECO ◽  
E. DE CORSO ◽  
D. LUCIDI ◽  
R. DELI ◽  
...  
Keyword(s):  
Case Report ◽  
Surgical Treatment ◽  
Clinical Presentation ◽  
Eagle’S Syndrome

scholarly journals Surgical treatment of Eagle’s Syndrome through intraoral access: a case report and literature review

2021 ◽  
Vol 1 (1) ◽  
pp. 15-21
Author(s):  
Rodrigo Cristhian Avelino Bezerra ◽  
Jonas Nogueira Ferreira Maciel Gusmão ◽  
Bruno Frota Amora Silva ◽  
Rodrigo Lemos Alves ◽  
Eliardo Silveira Santos ◽  
...  
Keyword(s):  
Case Report ◽  
Surgical Treatment ◽  
Literature Review ◽  
Facial Pain ◽  
Clinical Case ◽  
Styloid Process ◽  
Eagle’S Syndrome ◽  
Intraoral Approach ◽  
Eagle Syndrome ◽  
Review Study

The styloid process is a bone projection that originates in the tympanic portion of the temporal bone. The enlongation of the styloid process, or the ossification of the styloid process, can originate a series of symptoms such as dysphagia, odynophagia, facial pain, otalgia, headache, tinnitus and trismus, establishing the clinical picture of Eagle Syndrome. In this report, we present an important clinical case of adult patient diagnosed with Eagle’s Syndrome who underwent surgery for reduction of the enlongated styloid process, by intraoral approach, added to a literature review study.

scholarly journals Orbital Cellulitis in Children: Experience of the Pediatric Service at Mohammed v Military Hospital

2021 ◽  
pp. 6-9
Author(s):  
Jihane Elmahi ◽  
A. Radi ◽  
M. Kmari ◽  
A. Hassani ◽  
R. Abilkasseme ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Surgical Treatment ◽  
Orbital Cellulitis ◽  
Military Hospital ◽  
Preseptal Cellulitis ◽  
Orbital Abscess ◽  
Pediatric Service ◽  
Micro Organisms ◽  
Positive Evolution ◽  
Multidisciplinary Patient Care

Background: Orbital cellulitis is a diagnostic and therapeutic emergency, jeopardizing the  vital and functional prognosis. This study aimed to analyze the epidemiological, therapeutic and evolutional aspects of orbital cellulitis cases treated at the pediatric service at Mohamed V military hospital. Patients and methods: retrospective study including all the children aged between 1 month and 15 years treated for orbital cellulitis at the pediatric service of the Mohamed V Hospital over a period of 3 years (1st January 2016-31st December 2019). Results: 24 cases of orbital cellulitis were gathered. Age varied between 1 month and 15 years with a median of age of 6. years. Feminine predominance (58%) was noted . The disease mainly involved the sinus (32%).Clinically, fever was present in 10 patients (41%),palpebral edema was universal, proptosis was noted in 5 cases(20.8%),chemosis and ptosis were noted in 4 cases(16.6%),bacteriological testing identified micro-organisms in 3 cases. An orbital CT scan was performed in all cases of our study, showing preseptal cellulitis in 14 cases (58.3%), orbital cellulitis in 3 cases(12.5%),and orbital abscess in 7 cases. The medical treatment consisted of ceftriaxone, metronidazole and aminoside or amoxicilline clavulanic acid, corticosteroid therapy prescribed in 5 cases. Surgical treatment was indicated in 3 patients. The outcome of All cases was favorable. Conclusion: The majority of our cases had a positive evolution highlighting the advantage of an early diagnosis, and adapted antibiotic and a multidisciplinary patient care making the need for surgery rarely necessary.

Review of menopause advice given to patients undergoing bilateral oophorectomy

2021 ◽  
pp. 205336912110585
Author(s):  
Julia Elson ◽  
Deborah Bruce ◽  
Debra Holloway ◽  
Janice Rymer
Keyword(s):  
Health Care ◽  
Retrospective Study ◽  
Surgical Treatment ◽  
Health Care Professional ◽  
Teaching Hospital ◽  
Documentary Evidence ◽  
Bilateral Oophorectomy ◽  
Nice Guideline ◽  
Diagnosis And Management

The NICE Guideline (NG23) 2015 Menopause: Diagnosis and Management states that ‘women who are likely to go through the menopause as a result of medical or surgical treatment should be offered support and information about the menopause and fertility before they have their treatment, and a referral to a Health Care Professional with expertise in the menopause’. To investigate whether discussion about the surgery causing the menopause, and advice on possible treatments had been documented, I conducted a retrospective study of women undergoing bilateral oophorectomy at a central London teaching hospital from 1st April 2018 to 30th September 2018. Only 30% of women (8 out of 27) in this study had documentary evidence of having received menopause advice around the time of bilateral oophorectomy.

Sign in / Sign up

Export Citation Format

Share Document